Paragon 28 (FNA) Competitors

Artivion (NYSE:AORT) and Paragon 28 (NYSE:FNA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk.

Which has higher earnings and valuation, AORT or FNA?

Artivion has higher revenue and earnings than Paragon 28. Artivion is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$354M	2.33	-$30.69M	-$0.75	-26.71
Paragon 28	$216.39M	3.75	-$47.84M	-$0.58	-16.90

Does the MarketBeat Community favor AORT or FNA?

Paragon 28 received 14 more outperform votes than Artivion when rated by MarketBeat users. Likewise, 78.79% of users gave Paragon 28 an outperform vote while only 66.67% of users gave Artivion an outperform vote.

Company	Underperform	Outperform
Artivion	Outperform Votes 12 66.67%	Underperform Votes 6 33.33%
Paragon 28	Outperform Votes 26 78.79%	Underperform Votes 7 21.21%

Which has more risk and volatility, AORT or FNA?

Artivion has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Do analysts recommend AORT or FNA?

Artivion currently has a consensus target price of $23.50, suggesting a potential upside of 17.32%. Paragon 28 has a consensus target price of $17.67, suggesting a potential upside of 79.36%. Given Artivion's higher possible upside, analysts plainly believe Paragon 28 is more favorable than Artivion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Paragon 28	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is AORT or FNA more profitable?

Artivion has a net margin of -8.67% compared to Artivion's net margin of -22.11%. Paragon 28's return on equity of 3.02% beat Artivion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	-8.67%	3.02%	1.09%
Paragon 28	-22.11%	-22.51%	-13.98%

Does the media favor AORT or FNA?

In the previous week, Paragon 28 had 4 more articles in the media than Artivion. MarketBeat recorded 5 mentions for Paragon 28 and 1 mentions for Artivion. Artivion's average media sentiment score of 1.02 beat Paragon 28's score of 1.00 indicating that Paragon 28 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Paragon 28	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders believe in AORT or FNA?

86.4% of Artivion shares are held by institutional investors. Comparatively, 63.6% of Paragon 28 shares are held by institutional investors. 8.1% of Artivion shares are held by insiders. Comparatively, 15.3% of Paragon 28 shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Paragon 28 beats Artivion on 10 of the 17 factors compared between the two stocks.